Omada Health Inc (OMDA) FinancialsOMDAOmada Health Inc

Evaluating the bottom line, Omada Health, Inc. maintains a gross margin of 72.62%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.04%, while the net margin is 6.03%. These profitability ratios, combined with a Return on Equity (ROE) of 1.84%, provide a clear picture of how effectively OMDA converts its operational activities into shareholder value.

In the context of the broader market, OMDA competes directly with industry leaders such as YELP and LZ. With a market capitalization of $1.32B, it holds a leading position in the sector. When comparing efficiency, OMDA's gross margin of 72.62% stands against YELP's 84.05% and LZ's 68.16%. Such benchmarking helps identify whether Omada Health, Inc. is trading at a premium or discount relative to its financial performance.

Omada Health reported a significant increase in revenue, with Q2 2026 revenue at $87.83 million, up from $68.03 million in Q3 2025. The gross margin has improved to 72.62% in Q2 2026, indicating strong operational efficiency. However, net income remains inconsistent, with a net income of $5.29 million in Q2 2026 after previous losses.